Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Guida

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Materials (Basel, Switzerland)|October 13, 2021
Validity and Applicability of the Scaling Effects for Low Velocity Impact on Composite PlatesMichele Guida
Journal of Translational Medicine|February 14, 2026
Immunity and coagulationBenedetta Apollonio, Michele Guida
Frontiers in Immunology|November 16, 2020
Neoangiogenesis in Melanoma: An Issue in Biology and Systemic TreatmentDavide Quaresmini, Michele Guida
International Journal of Environmental Research and Public Health|December 11, 2022
Correction: Mancini et al. A Novel Strategy for the Assessment of Radon Risk Based on Indicators. <i>Int. J. Environ. Res. Public Health</i> 2021, <i>18</i>, 8089Simona Mancini, Martins Vilnitis, Michele Guida
Frontiers in Oncology|June 6, 2022
Editorial: The Evolving Role of Immunotherapy in Non-Melanoma Skin CancersMichele Guida, Pietro Quaglino, Paola Queirolo
International Journal of Environmental Research and Public Health|August 7, 2021
A Novel Strategy for the Assessment of Radon Risk Based on IndicatorsSimona Mancini, Martins Vilnitis, Michele Guida
BMC Complementary and Alternative Medicine|August 1, 2013
Herbal-drug interaction induced rhabdomyolysis in a liposarcoma patient receiving trabectedinSabino Strippoli, Vito Lorusso, Anna Albano, et al.
Biomedicines|October 27, 2022
Checkpoint Inhibitors Immunotherapy in Metastatic Melanoma: When to Stop Treatment?Ivana De Risi, Angela Monica Sciacovelli, Michele Guida
Materials (Basel, Switzerland)|January 10, 2019
Analysis of the Impact Dynamics of Shape Memory Alloy Hybrid Composites for Advanced ApplicationsMichele Guida, Andrea Sellitto, Francesco Marulo, et al.
Expert Opinion on Therapeutic Targets|March 27, 2012
Metastatic melanoma: the new era of targeted therapyMichele Guida, Salvatore Pisconti, Salvatore Pisconte, et al.
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Materials (Basel, Switzerland)|October 13, 2021
Validity and Applicability of the Scaling Effects for Low Velocity Impact on Composite PlatesMichele Guida
Journal of Translational Medicine|February 14, 2026
Immunity and coagulationBenedetta Apollonio, Michele Guida
Frontiers in Immunology|November 16, 2020
Neoangiogenesis in Melanoma: An Issue in Biology and Systemic TreatmentDavide Quaresmini, Michele Guida
International Journal of Environmental Research and Public Health|December 11, 2022
Correction: Mancini et al. A Novel Strategy for the Assessment of Radon Risk Based on Indicators. <i>Int. J. Environ. Res. Public Health</i> 2021, <i>18</i>, 8089Simona Mancini, Martins Vilnitis, Michele Guida
Frontiers in Oncology|June 6, 2022
Editorial: The Evolving Role of Immunotherapy in Non-Melanoma Skin CancersMichele Guida, Pietro Quaglino, Paola Queirolo
International Journal of Environmental Research and Public Health|August 7, 2021
A Novel Strategy for the Assessment of Radon Risk Based on IndicatorsSimona Mancini, Martins Vilnitis, Michele Guida
BMC Complementary and Alternative Medicine|August 1, 2013
Herbal-drug interaction induced rhabdomyolysis in a liposarcoma patient receiving trabectedinSabino Strippoli, Vito Lorusso, Anna Albano, et al.
Biomedicines|October 27, 2022
Checkpoint Inhibitors Immunotherapy in Metastatic Melanoma: When to Stop Treatment?Ivana De Risi, Angela Monica Sciacovelli, Michele Guida
Materials (Basel, Switzerland)|January 10, 2019
Analysis of the Impact Dynamics of Shape Memory Alloy Hybrid Composites for Advanced ApplicationsMichele Guida, Andrea Sellitto, Francesco Marulo, et al.
Expert Opinion on Therapeutic Targets|March 27, 2012
Metastatic melanoma: the new era of targeted therapyMichele Guida, Salvatore Pisconti, Salvatore Pisconte, et al.
Pageof 13